首页> 外文OA文献 >Response to Letter Regarding Article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy”

【2h】

Response to Letter Regarding Article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy”

机译：回应关于文章的信，“高密度脂蛋白胆固醇，尺寸，粒子数和残留的血管风险后有效的他汀类药物治疗”

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Samia Mora; Robert J. Glynn; Paul M Ridker;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy [J] . Mora Samia, Glynn Robert J., Ridker Paul M. Circulation: An Official Journal of the American Heart Association . 2013,第11期

机译：强力他汀类药物治疗后高密度脂蛋白胆固醇，大小，颗粒数和残余血管风险
2. Response to Letter Regarding Article, "Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)" [J] . Khera Amit V., Everett Brendan M., Caulfield Michael P., Circulation: An Official Journal of the American Heart Association . 2014,第17期

机译：对有关“脂蛋白（a）浓度，瑞舒伐他汀治疗和残余血管风险的文章：JUPITER试验（使用他汀类药物预防的合理性：评估瑞舒伐他汀的干预试验）”的信函的答复
3. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein b, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) [J] . MoraS., GlynnR.J., BoekholdtS.M., Journal of the American College of Cardiology . 2012,第17期

机译：在有效的他汀类药物治疗后，治疗中非高密度脂蛋白胆固醇，载脂蛋白b，甘油三酸酯和脂质比率与残余血管风险的关系：JUPITER（在预防中使用他汀类药物的正当性：评估瑞舒伐他汀的干预试验）
4. Photosensitizer-loaded nanoparticles: a strategy to enhance the vascular occlusionin response to photodynamic therapy [C] . Angelica Vargas, Robert Gurny, Florence Delie Annual meeting exposition of the Controlled Release Society . 2005

机译：装载光敏剂的纳米颗粒：增强对光动力疗法的血管阻塞的策略
5. Proteomic analysis to identify candidate genes influencing high-density lipoprotein particle size in obesity. [D] . Collins, Lisamarie Anne. 2010

机译：蛋白质组学分析可识别影响肥胖症中高密度脂蛋白粒径的候选基因。
6. Response to letter regarding article High-DensityLipoprotein Cholesterol Size Particle Number and Residual Vascular Risk AfterPotent Statin Therapy. [O] . Samia Mora, Robert J Glynn, Paul M Ridker -1

机译：对有关高密度的文章的回复脂蛋白胆固醇大小颗粒数和术后残余血管风险有效的他汀类药物疗法。
7. On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy JUPITER (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) [O] . Mora Samia, Glynn Robert J., Boekholdt S. Matthijs, 2012

机译：治疗后非高密度脂蛋白胆固醇，载脂蛋白B，甘油三酸酯和脂质比率与强力他汀类药物治疗后残余血管风险的关系JUPITER（使用他汀类药物预防的合理性：评估瑞舒伐他汀的干预试验）

Response to Letter Regarding Article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy”

著录项

引文网络

相似文献

相关主题

期刊订阅